Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer. [electronic resource]
Producer: 19950605Description: 1136-43 p. digitalISSN:- 0732-183X
- Adult
- Anemia, Aplastic -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Drug Administration Schedule
- Drug Resistance
- Female
- Gastrointestinal Diseases -- chemically induced
- Humans
- Length of Stay
- Lymphatic Metastasis
- Middle Aged
- Mouth Mucosa -- drug effects
- Neutropenia -- chemically induced
- Novobiocin -- administration & dosage
- Prospective Studies
- Stomatitis -- chemically induced
- Thiotepa -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.